DFCM
SMMT icon

Dark Forest Capital Management’s Summit Therapeutics SMMT Stock Holding History

Dark Forest Capital Management’s Portfolio SMMT Stock Details SMMT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.55M Buy
243,607
+162,827
+202% +$2.89M 0.23% 118
2026
Q1 		$1.53M Sell
80,780
-6,289
-7% -$102K 0.14% 235
2025
Q4 		$1.52M Sell
87,069
-25,130
-22% -$473K 0.07% 500
2025
Q3 		$2.32M Buy
+112,199
New +$2.72M 0.09% 410
2025
Q2 		– Sell
-93,548
Closed -$1.8M – 1488
2025
Q1 		$1.8M Buy
+93,548
New +$1.88M 0.08% 423

Other funds holding SMMT

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Dark Forest Capital Management's SMMT Position: Q2 2026 in Review

Dark Forest Capital Management increased its Summit Therapeutics (SMMT) stake by 202% in Q2 2026, buying an estimated $2.89M and bringing the position to 243,607 shares worth $3.55M. The position accounts for 0.23% of the portfolio, ranked #118.

Dark Forest Capital Management first reported a position in SMMT in Q1 2025 and has held it in 5 quarters since. 242 funds tracked by Wall St. Rank hold SMMT as of Q2 2026.

  • Dark Forest Capital Management held 243,607 shares of Summit Therapeutics worth $3.55M as of Q2 2026.
  • Dark Forest Capital Management bought 162,827 Summit Therapeutics shares in Q2 2026, an estimated $2.89M.
  • Summit Therapeutics made up 0.23% of Dark Forest Capital Management's portfolio in Q2 2026, its #118 holding.
  • Dark Forest Capital Management first reported a position in Summit Therapeutics in Q1 2025 and has held it in 5 quarters since.
  • 242 funds tracked by Wall St. Rank held Summit Therapeutics as of Q2 2026.

Based on Dark Forest Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.